Abstract
Background A genetic neurodevelopmental diagnosis (GND) impacts all aspects of a child and family’s life. GNDs are rare; most have limited natural history data. We aimed to understand parents’ experiences around data acquisition about their child’s GNDs which can help inform clinical practice.
Design and participants This analysis is part of the UK multicentre GenROC study. We conducted 17 semi-structured interviews with parents of children with GNDs (aged 0-15 years). Data were analysed following the principles of thematic analysis.
Results Five main themes are reported:
Impact on the family around a genetic diagnosis Distress results from diagnosis wait, the act of receiving it, associated irreversibility (loss of hope) and family/reproductive implications.
GNDs and Uncertainty: Lack of data and rareness causes uncertainty for the future.
Relationships with health professionals Positive where parents are empowered and feel part of the team; Negative –parents feel not heard/believed or lack of expertise/understanding.
Parent mental health GNDs can be a significant burden to family life. Need for advocating for services is a negative impact. Isolation through rareness is a factor – this can be helped by support networks which mostly consist of gene specific Facebook groups.
Development of positive parent identities including that of advocate, professional and educator.
Conclusions GNDs represent a major challenge for families, clinicians and service providers. Distressed parents are struggling to cope with challenges and suffer poor mental health. Psychosocial support, better signposting, and health professional education may help.
Patient contribution PPI group contributed to topic guide development and commented on findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
For the purpose of open access, the author has applied a CC-BY public copyright licence to any author accepted manuscript version arising from this submission. KL and GenROC is supported by the National Institute for Health and Care Research Doctoral Research Fellowship 302303: The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The GenROC study protocol was reviewed by the NHS Research Ethics Committee (Nottingham REC, United Kingdom). They gave ethical approval approval on 15 December 2022 and NHS Health Research Authority gave approval on 9 February 2023.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Clinically interpreted variants and associated phenotypes from the GenROC study are available through DECIPHER (https://www.deciphergenomics.org/). Transcripts from interviews are not available due to sensitivity of discussions and risk to vulnerable children.
